Global Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027

SKU ID :QYR-17246138 | Published Date: 22-Jan-2021 | No. of pages: 95
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Prostate Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Biological Therapy 1.2.3 Chemotherapy 1.3 Market by Application 1.3.1 Global Prostate Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Research Institution 1.3.4 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Prostate Cancer Treatment Market Perspective (2016-2027) 2.2 Prostate Cancer Treatment Growth Trends by Regions 2.2.1 Prostate Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Prostate Cancer Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Prostate Cancer Treatment Industry Dynamic 2.3.1 Prostate Cancer Treatment Market Trends 2.3.2 Prostate Cancer Treatment Market Drivers 2.3.3 Prostate Cancer Treatment Market Challenges 2.3.4 Prostate Cancer Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Prostate Cancer Treatment Players by Revenue 3.1.1 Global Top Prostate Cancer Treatment Players by Revenue (2016-2021) 3.1.2 Global Prostate Cancer Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Prostate Cancer Treatment Revenue 3.4 Global Prostate Cancer Treatment Market Concentration Ratio 3.4.1 Global Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Treatment Revenue in 2020 3.5 Prostate Cancer Treatment Key Players Head office and Area Served 3.6 Key Players Prostate Cancer Treatment Product Solution and Service 3.7 Date of Enter into Prostate Cancer Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Prostate Cancer Treatment Breakdown Data by Type 4.1 Global Prostate Cancer Treatment Historic Market Size by Type (2016-2021) 4.2 Global Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027) 5 Prostate Cancer Treatment Breakdown Data by Application 5.1 Global Prostate Cancer Treatment Historic Market Size by Application (2016-2021) 5.2 Global Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Prostate Cancer Treatment Market Size (2016-2027) 6.2 North America Prostate Cancer Treatment Market Size by Type 6.2.1 North America Prostate Cancer Treatment Market Size by Type (2016-2021) 6.2.2 North America Prostate Cancer Treatment Market Size by Type (2022-2027) 6.2.3 North America Prostate Cancer Treatment Market Size by Type (2016-2027) 6.3 North America Prostate Cancer Treatment Market Size by Application 6.3.1 North America Prostate Cancer Treatment Market Size by Application (2016-2021) 6.3.2 North America Prostate Cancer Treatment Market Size by Application (2022-2027) 6.3.3 North America Prostate Cancer Treatment Market Size by Application (2016-2027) 6.4 North America Prostate Cancer Treatment Market Size by Country 6.4.1 North America Prostate Cancer Treatment Market Size by Country (2016-2021) 6.4.2 North America Prostate Cancer Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Prostate Cancer Treatment Market Size (2016-2027) 7.2 Europe Prostate Cancer Treatment Market Size by Type 7.2.1 Europe Prostate Cancer Treatment Market Size by Type (2016-2021) 7.2.2 Europe Prostate Cancer Treatment Market Size by Type (2022-2027) 7.2.3 Europe Prostate Cancer Treatment Market Size by Type (2016-2027) 7.3 Europe Prostate Cancer Treatment Market Size by Application 7.3.1 Europe Prostate Cancer Treatment Market Size by Application (2016-2021) 7.3.2 Europe Prostate Cancer Treatment Market Size by Application (2022-2027) 7.3.3 Europe Prostate Cancer Treatment Market Size by Application (2016-2027) 7.4 Europe Prostate Cancer Treatment Market Size by Country 7.4.1 Europe Prostate Cancer Treatment Market Size by Country (2016-2021) 7.4.2 Europe Prostate Cancer Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Prostate Cancer Treatment Market Size (2016-2027) 8.2 Asia-Pacific Prostate Cancer Treatment Market Size by Type 8.2.1 Asia-Pacific Prostate Cancer Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Prostate Cancer Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Prostate Cancer Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Prostate Cancer Treatment Market Size by Application 8.3.1 Asia-Pacific Prostate Cancer Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Prostate Cancer Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Prostate Cancer Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Prostate Cancer Treatment Market Size by Region 8.4.1 Asia-Pacific Prostate Cancer Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Prostate Cancer Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Prostate Cancer Treatment Market Size (2016-2027) 9.2 Latin America Prostate Cancer Treatment Market Size by Type 9.2.1 Latin America Prostate Cancer Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Prostate Cancer Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Prostate Cancer Treatment Market Size by Type (2016-2027) 9.3 Latin America Prostate Cancer Treatment Market Size by Application 9.3.1 Latin America Prostate Cancer Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Prostate Cancer Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Prostate Cancer Treatment Market Size by Application (2016-2027) 9.4 Latin America Prostate Cancer Treatment Market Size by Country 9.4.1 Latin America Prostate Cancer Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Prostate Cancer Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Prostate Cancer Treatment Market Size (2016-2027) 10.2 Middle East & Africa Prostate Cancer Treatment Market Size by Type 10.2.1 Middle East & Africa Prostate Cancer Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Prostate Cancer Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Prostate Cancer Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Prostate Cancer Treatment Market Size by Application 10.3.1 Middle East & Africa Prostate Cancer Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Prostate Cancer Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Prostate Cancer Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Prostate Cancer Treatment Market Size by Country 10.4.1 Middle East & Africa Prostate Cancer Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Prostate Cancer Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Tolmar 11.1.1 Tolmar Company Details 11.1.2 Tolmar Business Overview 11.1.3 Tolmar Prostate Cancer Treatment Introduction 11.1.4 Tolmar Revenue in Prostate Cancer Treatment Business (2016-2021) 11.1.5 Tolmar Recent Development 11.2 Astellas Pharma 11.2.1 Astellas Pharma Company Details 11.2.2 Astellas Pharma Business Overview 11.2.3 Astellas Pharma Prostate Cancer Treatment Introduction 11.2.4 Astellas Pharma Revenue in Prostate Cancer Treatment Business (2016-2021) 11.2.5 Astellas Pharma Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Company Details 11.3.2 AstraZeneca Business Overview 11.3.3 AstraZeneca Prostate Cancer Treatment Introduction 11.3.4 AstraZeneca Revenue in Prostate Cancer Treatment Business (2016-2021) 11.3.5 AstraZeneca Recent Development 11.4 Ferring Pharmaceuticals 11.4.1 Ferring Pharmaceuticals Company Details 11.4.2 Ferring Pharmaceuticals Business Overview 11.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Introduction 11.4.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Treatment Business (2016-2021) 11.4.5 Ferring Pharmaceuticals Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Prostate Cancer Treatment Introduction 11.5.4 Johnson & Johnson Revenue in Prostate Cancer Treatment Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Abbott 11.6.1 Abbott Company Details 11.6.2 Abbott Business Overview 11.6.3 Abbott Prostate Cancer Treatment Introduction 11.6.4 Abbott Revenue in Prostate Cancer Treatment Business (2016-2021) 11.6.5 Abbott Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Details 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Prostate Cancer Treatment Introduction 11.7.4 Sanofi Revenue in Prostate Cancer Treatment Business (2016-2021) 11.7.5 Sanofi Recent Development 11.8 Ipsen 11.8.1 Ipsen Company Details 11.8.2 Ipsen Business Overview 11.8.3 Ipsen Prostate Cancer Treatment Introduction 11.8.4 Ipsen Revenue in Prostate Cancer Treatment Business (2016-2021) 11.8.5 Ipsen Recent Development 11.9 Novartis 11.9.1 Novartis Company Details 11.9.2 Novartis Business Overview 11.9.3 Novartis Prostate Cancer Treatment Introduction 11.9.4 Novartis Revenue in Prostate Cancer Treatment Business (2016-2021) 11.9.5 Novartis Recent Development 11.10 Bayer 11.10.1 Bayer Company Details 11.10.2 Bayer Business Overview 11.10.3 Bayer Prostate Cancer Treatment Introduction 11.10.4 Bayer Revenue in Prostate Cancer Treatment Business (2016-2021) 11.10.5 Bayer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Biological Therapy Table 3. Key Players of Chemotherapy Table 4. Global Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Prostate Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Prostate Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Prostate Cancer Treatment Market Share by Regions (2016-2021) Table 8. Global Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Prostate Cancer Treatment Market Share by Regions (2022-2027) Table 10. Prostate Cancer Treatment Market Trends Table 11. Prostate Cancer Treatment Market Drivers Table 12. Prostate Cancer Treatment Market Challenges Table 13. Prostate Cancer Treatment Market Restraints Table 14. Global Prostate Cancer Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Prostate Cancer Treatment Market Share by Players (2016-2021) Table 16. Global Top Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Treatment as of 2020) Table 17. Ranking of Global Top Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Prostate Cancer Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Prostate Cancer Treatment Product Solution and Service Table 21. Date of Enter into Prostate Cancer Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Prostate Cancer Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Prostate Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Prostate Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Prostate Cancer Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Prostate Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Prostate Cancer Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Prostate Cancer Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. Tolmar Company Details Table 62. Tolmar Business Overview Table 63. Tolmar Prostate Cancer Treatment Product Table 64. Tolmar Revenue in Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 65. Tolmar Recent Development Table 66. Astellas Pharma Company Details Table 67. Astellas Pharma Business Overview Table 68. Astellas Pharma Prostate Cancer Treatment Product Table 69. Astellas Pharma Revenue in Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 70. Astellas Pharma Recent Development Table 71. AstraZeneca Company Details Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Prostate Cancer Treatment Product Table 74. AstraZeneca Revenue in Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 75. AstraZeneca Recent Development Table 76. Ferring Pharmaceuticals Company Details Table 77. Ferring Pharmaceuticals Business Overview Table 78. Ferring Pharmaceuticals Prostate Cancer Treatment Product Table 79. Ferring Pharmaceuticals Revenue in Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 80. Ferring Pharmaceuticals Recent Development Table 81. Johnson & Johnson Company Details Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Prostate Cancer Treatment Product Table 84. Johnson & Johnson Revenue in Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 85. Johnson & Johnson Recent Development Table 86. Abbott Company Details Table 87. Abbott Business Overview Table 88. Abbott Prostate Cancer Treatment Product Table 89. Abbott Revenue in Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 90. Abbott Recent Development Table 91. Sanofi Company Details Table 92. Sanofi Business Overview Table 93. Sanofi Prostate Cancer Treatment Product Table 94. Sanofi Revenue in Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 95. Sanofi Recent Development Table 96. Ipsen Company Details Table 97. Ipsen Business Overview Table 98. Ipsen Revenue in Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 99. Ipsen Recent Development Table 100. Novartis Company Details Table 101. Novartis Business Overview Table 102. Novartis Prostate Cancer Treatment Product Table 103. Novartis Revenue in Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 104. Novartis Recent Development Table 105. Bayer Company Details Table 106. Bayer Business Overview Table 107. Bayer Prostate Cancer Treatment Product Table 108. Bayer Revenue in Prostate Cancer Treatment Business (2016-2021) & (US$ Million) Table 109. Bayer Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Prostate Cancer Treatment Market Share by Type: 2020 VS 2027 Figure 2. Biological Therapy Features Figure 3. Chemotherapy Features Figure 4. Global Prostate Cancer Treatment Market Share by Application: 2020 VS 2027 Figure 5. Hospital Case Studies Figure 6. Research Institution Case Studies Figure 7. Clinic Case Studies Figure 8. Prostate Cancer Treatment Report Years Considered Figure 9. Global Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Prostate Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Prostate Cancer Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Prostate Cancer Treatment Market Share by Regions (2022-2027) Figure 13. Global Prostate Cancer Treatment Market Share by Players in 2020 Figure 14. Global Top Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Prostate Cancer Treatment Revenue in 2020 Figure 16. Global Prostate Cancer Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Prostate Cancer Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Prostate Cancer Treatment Market Share by Type (2016-2027) Figure 20. North America Prostate Cancer Treatment Market Share by Application (2016-2027) Figure 21. North America Prostate Cancer Treatment Market Share by Country (2016-2027) Figure 22. United States Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Prostate Cancer Treatment Market Share by Type (2016-2027) Figure 26. Europe Prostate Cancer Treatment Market Share by Application (2016-2027) Figure 27. Europe Prostate Cancer Treatment Market Share by Country (2016-2027) Figure 28. Germany Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Prostate Cancer Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Prostate Cancer Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Prostate Cancer Treatment Market Share by Region (2016-2027) Figure 38. China Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Prostate Cancer Treatment Market Share by Type (2016-2027) Figure 46. Latin America Prostate Cancer Treatment Market Share by Application (2016-2027) Figure 47. Latin America Prostate Cancer Treatment Market Share by Country (2016-2027) Figure 48. Mexico Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Prostate Cancer Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Prostate Cancer Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Prostate Cancer Treatment Market Share by Country (2016-2027) Figure 54. Turkey Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Tolmar Revenue Growth Rate in Prostate Cancer Treatment Business (2016-2021) Figure 58. Astellas Pharma Revenue Growth Rate in Prostate Cancer Treatment Business (2016-2021) Figure 59. AstraZeneca Revenue Growth Rate in Prostate Cancer Treatment Business (2016-2021) Figure 60. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Treatment Business (2016-2021) Figure 61. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Treatment Business (2016-2021) Figure 62. Abbott Revenue Growth Rate in Prostate Cancer Treatment Business (2016-2021) Figure 63. Sanofi Revenue Growth Rate in Prostate Cancer Treatment Business (2016-2021) Figure 64. Ipsen Revenue Growth Rate in Prostate Cancer Treatment Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Prostate Cancer Treatment Business (2016-2021) Figure 66. Bayer Revenue Growth Rate in Prostate Cancer Treatment Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
Tolmar Astellas Pharma AstraZeneca Ferring Pharmaceuticals Johnson & Johnson Abbott Sanofi Ipsen Novartis Bayer
  • PRICE
  • $3900
    $7800
    $5850
    Buy Now

Our Clients